← Back to Search

Communities That HEAL Intervention for Opioid Use Disorder

N/A
Waitlist Available
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 19-30
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new intervention aimed at reducing opioid overdose deaths by 40% in 67 communities that are highly affected by addiction.

Who is the study for?
The HEALing Communities Study is for communities in Kentucky, Ohio, Massachusetts, or New York that are heavily impacted by opioid overdoses. Eligible communities must have a high rate of opioid-related deaths and be willing to implement strategies like medication-assisted treatment (MOUD), overdose training, and naloxone distribution.
What is being tested?
This study tests the 'Communities That HEAL' intervention aimed at reducing opioid overdose deaths by 40%. Some communities will start the program right away while others will wait to begin. The effectiveness of this community-wide approach on preventing deaths from opioids is being compared.
What are the potential side effects?
Since this trial involves community interventions rather than medications, there aren't traditional side effects. However, potential challenges could include resistance to change within communities or difficulties in coordinating across different sectors like healthcare and justice.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 19-30
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 19-30 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of opioid overdose deaths
Secondary study objectives
Opioids
Buprenorphine
Naloxone

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wave 2 - Wait-list comparisonExperimental Treatment1 Intervention
Communities in Wave 2 will continue usual care during the first 30 months of the trial. At month 31, Wave 2 communities will begin receiving the CTH intervention.
Group II: Wave 1 - InterventionExperimental Treatment1 Intervention
Communities in Wave 1 will receive the CTH intervention during the first 30 months of the trial. The intervention will include 3 components: community engagement to assist key stakeholders in applying evidence-based practices to addressing their opioid crisis, a menu of evidence-based practices for communities to select and implement, and a communications campaign to build demand for evidence-based practices to address overdose and opioid use disorder.

Find a Location

Who is running the clinical trial?

Boston Medical CenterOTHER
401 Previous Clinical Trials
886,316 Total Patients Enrolled
Columbia UniversityOTHER
1,483 Previous Clinical Trials
2,629,928 Total Patients Enrolled
RTI InternationalLead Sponsor
196 Previous Clinical Trials
819,732 Total Patients Enrolled

Media Library

Communities That HEAL Clinical Trial Eligibility Overview. Trial Name: NCT04111939 — N/A
Opioid Use Disorder Clinical Trial 2023: Communities That HEAL Highlights & Side Effects. Trial Name: NCT04111939 — N/A
Communities That HEAL 2023 Treatment Timeline for Medical Study. Trial Name: NCT04111939 — N/A
Opioid Use Disorder Research Study Groups: Wave 2 - Wait-list comparison, Wave 1 - Intervention
~11 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top